Page 2 - Clinical Lymphoma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical lymphoma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Lymphoma Today - Breaking & Trending Today

Study points to racial and social barriers that block treatment for multiple myeloma

Study points to racial and social barriers that block treatment for multiple myeloma
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United States , Theresa Keegan , Naseems Esteghamat , Naseem Esteghamat , A Uc Davis Health , Marrow Transplant Research , International Blood , Uc Davis Comprehensive Cancer Center , Clinical Lymphoma , California Cancer Registry , California Patient Discharge , African American , Multiple Myeloma , Population Based Study ,

New study points to racial and social barriers that block treatment for multiple myeloma

Socioeconomic factors are preventing some patients from accessing common treatment to stop progression of multiple myeloma. ....

United States , Stanford University , Aarons Rosenberg , Saraj Schonfeld , Theresa Keegan , Naseem Esteghamat , Lindsaym Morton , Ann Brunson , Christal Meyer , Bryan Valcarcel , Jefferyj Auletta , Juliannejp Cooley , Lori Muffly , Renata Abrah , National Cancer Institute , Uc Davis Comprehensive Cancer Center , A Uc Davis Health , International Blood , Ted Wun Of The Comprehensive Cancer Center , Marrow Transplant Research , National Marrow Donor Program Be , Clinical Lymphoma , Comprehensive Cancer Center , California Cancer Registry , California Patient Discharge , African American ,

Ofatumumab, Methylprednisone, Lenalidomide Regimen Feasible as Frontline Therapy in CLL/SLL

Investigators reported the regimen had a tolerable safety profile, though they said its use may be limited due to the development of newer therapies. ....

Sebastian Kaulitzki , Abbvie Genentech , Eva Sahakian , H Lee Moffitt Cancer Center , Research Institute , Clinical Lymphoma , Moffitt Cancer Center ,

Elderly Patients With DLBCL Face Poor Overall Survival, High Costs With R-GemOx Treatment

Treatment with R-GemOx was associated with significant health care resource utilization, high costs surrounding treatment, and low overall survival in elderly patients with diffuse large B-cell lymphoma (DLBCL). ....

Sherry Young , Clinical Lymphoma , Diffuse Largeb Cell Lymphoma ,

VPEQ-CSPS Validated as Tool to Assess Patient Preferences for MM Treatment

Researchers sought to confirm the effectiveness of a novel tool designed to assist patients with MM in assessing their preferences regarding treatment. The VPEQ-CSPS was evaluated and validated as an effective tool for helping patients with MM to assess and incorporate their wishes and values into their treatment. ....

International Myeloma Foundation , Clinical Lymphoma , Preferences Elicitation Questionnaire , Survival Preference Scale ,